1 year return (CAGR)
41.32%
Brainstorm Cell Therapeutics Inc Exchange (NASDAQ, USD)
BCLI
1.00
+0.05 (+5.26%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-44.60%
5 year return (CAGR)
-54.50%
10 year return (CAGR)
-30.18%
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
11.03M
Price/Sales
12.53
Ent value
23.40M
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-41.32%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 0.95 |
| Daily high | 1.08 |
| Daily low | 0.95 |
| Daily Volume | 12K |
| All-time high | 776.25 |
| 1y analyst estimate | 17.00 |
| Beta | 0.23 |
| EPS (TTM) | -0.95 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| BCLI | S&P500 | |
| Current price drop from All-time high | -99.87% | -1.79% |
| Highest price drop | -99.94% | -56.47% |
| Date of highest drop | 17 Feb 2026 | 9 Mar 2009 |
| Avg drop from high | -89.73% | -10.65% |
| Avg time to new high | 145 days | 12 days |
| Max time to new high | 5388 days | 1805 days |
News
